Hansoh Pharmaceutical Group Company Limited
HNSPF
$5.20
$0.4910.40%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 114.43M | 114.98M | 188.19M | 189.82M | 137.71M |
| Total Depreciation and Amortization | 12.83M | 12.89M | 14.97M | 15.10M | 12.57M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.10M | -36.28M | -29.52M | -29.78M | -23.74M |
| Change in Net Operating Assets | -9.14M | -9.19M | 11.58M | 11.68M | 9.90M |
| Cash from Operations | 82.02M | 82.41M | 185.21M | 186.81M | 136.44M |
| Capital Expenditure | -8.35M | -8.39M | -7.03M | -7.09M | -8.79M |
| Sale of Property, Plant, and Equipment | 350.20K | 351.90K | 1.31M | 1.32M | 594.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -253.40M | -254.62M | 169.29M | 170.75M | 10.42M |
| Cash from Investing | -261.39M | -262.66M | 163.56M | 164.98M | 2.22M |
| Total Debt Issued | 0.00 | 0.00 | 250.00M | 250.00M | 450.00M |
| Total Debt Repaid | -5.63M | -5.63M | -2.35B | -2.35B | -454.99M |
| Issuance of Common Stock | 0.00 | 0.00 | 16.59M | 16.59M | 0.00 |
| Repurchase of Common Stock | 0.00 | 0.00 | -16.85M | -16.85M | -17.71M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -129.17M | -129.79M | -- | -- | -45.16M |
| Other Financing Activities | 0.00 | 0.00 | -1.60M | -1.60M | -2.89M |
| Cash from Financing | -129.95M | -130.58M | -289.74M | -292.25M | -48.70M |
| Foreign Exchange rate Adjustments | -1.61M | -1.62M | -2.71M | -2.73M | -3.46M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -310.94M | -312.45M | 56.32M | 56.81M | 86.50M |